青少年HPV疫苗自我同意的可接受性:英格兰西南部质性研究
该研究在英格兰西南部两个地方当局2017/18和2018/19项目年度,对53名参与者进行半结构化访谈,包括1名卫生服务管理者、3名免疫护士、8名学校工作人员、19名年轻女性和22名家长。研究发现大多数参与者不完全了解青少年可自我同意接种疫苗的法律框架,实践中正式自我同意很少见,对亲子信任和家校信任的担忧是主要障碍。
要点
- 多数参与者不了解青少年可自我同意接种疫苗的法律框架。
- 强烈预设家长应决定子女健康相关事务。
- 12-13岁接种年龄使参与者不愿支持自我同意。
核心结论
- 青少年自我同意HPV疫苗的可接受性受公众和专业对青少年权利与能力的认知影响。
- 对自我同意影响家庭内及专业人员和家庭之间关系的担忧是未解决问题。
研究设计与样本
- 在英格兰西南部两个地方当局2017/18和2018/19项目年度进行的质性研究。
- 对53名参与者进行半结构化数字录音访谈,含1名卫生服务管理者、3名免疫护士、5名替代教育机构工作人员、3名主流学校工作人员、19名年轻女性和22名家长。
- 录音逐字转录,使用NVivo软件辅助进行主题分析。
主要发现
- 大多数参与者不完全了解允许青少年自我同意接种疫苗的法律框架。
- 存在强烈预设认为家长应决定影响子女健康的事务。
- HPV疫苗首选接种年龄12-13岁促使参与者不愿支持自我同意,认为可能破坏家长与学校工作人员之间及家庭内的信任。
- 实践中正式自我同意很少见。
临床怎么用
- 开展免疫接种时需考虑公众和专业对青少年自我同意权利与能力的认知差异。
- 实施自我同意流程时应关注其对家庭关系和专业信任的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human Papillomavirus (HPV) vaccination programmes have the potential to reduce the incidence of cervical cancer. The preferred age for HPV vaccination is 12-13 years for optimal benefit. The legal framework in England allows adolescents to be vaccinated without parental consent if they are assessed as competent. A 'South West Template Pathway on Self Consent for School Aged Immunisations' was developed to improve uptake of immunisations in south-west England. STUDY AIM: To examine how acceptable the new procedures are to the young women, parents and carers, school staff and immunisation nurses involved. METHODS: The research was undertaken in two local authorities in south-west England during the 2017/18 and 2018/19 programme years. Semi-structured digitally recorded interviews were undertaken with 53 participants: one health service manager, three immunisation nurses, five staff at alternative education providers, three staff at mainstream schools, 19 young women and 22 parents. All recordings were transcribed verbatim and thematic analysis was undertaken, assisted by NVivo software. RESULTS: Most participants were not fully aware of the legal framework that enables a young person to self-consent to vaccination. There was a strong presumption that parents should make decisions affecting the health of their children. The preferred age at which the HPV vaccination is administered (12-13 years) contributed to reluctance in endorsing self-consent which was thought to have the potential to break down trust between parents and school staff, and within families. In practice, formal self-consent was rare. CONCLUSION: Unresolved issues in relation to adolescent self-consent include public and professional perceptions of young people's rights and abilities to take responsibility for decisions affecting their health, and concerns about the impact of self-consent on relationships both within families and between professionals and the families they serve.
引用
- Audrey S, Farr M, Roderick M, et al. How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England. Vaccine. 2020. PMID: 33041101. doi:10.1016/j.vaccine.2020.09.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。